-
Review
December 28, 2022
- Non-alcoholic fatty liver disease: Definition and subtypes
- Seul Ki Han, Soon Koo Baik, Moon Young Kim
- Clin Mol Hepatol. 2023;29(suppl):S5-S16.
Articles in E-pub version are posted online ahead of regular printed publication.
- Original Article
- Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
- Yee Hui Yeo, Jamil S. Samaan, Wee Han Ng, Peng-Sheng Ting, Hirsh Trivedi, Aarshi Vipani, Walid Ayoub, Ju Dong Yang, Omer Liran, Brennan Spiegel, Alexander Kuo
- Received March 3, 2023 Accepted March 21, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0089 [Accepted]
-
View: 235 Download: 25
- Editorial
- Toward user-friendly and evidence-based practice guidelines for hepatocellular carcinoma
- Do Young Kim
- Received March 15, 2023 Accepted March 15, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0107 [Accepted]
-
View: 73 Download: 3
- Review
- Clinical practice guidelines and real-life practice in hepatocellular carcinoma: a Japanese perspective
- Hironori Koga, Hideki Iwamoto, Hiroyuki Suzuki, Shigeo Shimose, Masahito Nakano, Takumi Kawaguchi
- Received March 12, 2023 Accepted March 20, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0102 [Accepted]
-
View: 128 Download: 19
- Editorial
- Challenges in Translating Clinical Practice Guidelines into Real-Life Practice for the management of hepatocellular carcinoma in Taiwan
- San-Chi Chen
- Received March 11, 2023 Accepted March 17, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0101 [Accepted]
-
View: 83 Download: 4
- Clinical practice guidelines and real-world practice for hepatocellular carcinoma in Taiwan: Bridging the gap
- Shen-Yung Wang
- Received February 28, 2023 Accepted March 16, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0082 [Accepted]
-
View: 64 Download: 4
- Screening strategies for non-alcoholic fatty liver disease: a holistic approach is needed
- Philipp Kasper, Münevver Demir, Hans-Michael Steffen
- Received February 15, 2023 Accepted March 16, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0059 [Accepted]
-
View: 62 Download: 4
- Is liver biopsy mandatory to identify immune-tolerant phase of chronic hepatitis B?
- Joo Hyun Oh, Dong Hyun Sinn
- Received February 10, 2023 Accepted March 15, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0054 [Accepted]
-
View: 49 Download: 1
- Review
- Acute -on- Chronic liver failure – Terminology, Mechanisms and Management
- Vinay Kumar BR, Shiv Kumar Sarin
- Received April 16, 2022 Accepted February 25, 2023
-
DOI: https://doi.org/10.3350/cmh.2022.0103 [Accepted]
-
View: 139 Download: 25
- Editorial
- Management of Hepatocellular Carcinoma in China: Seeking Common Grounds While Reserving Differences
- Tian Yang, Ming-Da Wang, Xin-Fei Xu, Chao Li, Han Wu, Feng Shen
- Received March 14, 2023 Accepted March 15, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0106 [Accepted]
-
View: 106 Download: 11
- The effect of moderate alcohol consumption on nonalcoholic fatty liver disease
- Ji-Won Park, Ki Tae Suk
- Received March 1, 2023 Accepted March 15, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0085 [Accepted]
-
View: 82 Download: 12
- What should be done to reduce the discrepancy between guidelines and real-life practice for HCC in Korea?
- Min Kyung Park, Yoon Jun Kim
- Received February 28, 2023 Accepted March 14, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0080 [Accepted]
-
View: 61 Download: 0
- The clinical management of HCC in China: progresses and challenges
- Shan Shan, Jidong Jia
- Received February 28, 2023 Accepted March 13, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0077 [Accepted]
-
View: 87 Download: 10
- The current trends in the health burden of primary liver cancer across the globe
- Peter Konyn, Aijaz Ahmed, Donghee Kim
- Received March 4, 2023 Accepted March 11, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0092 [Accepted]
-
View: 110 Download: 6
- Changing the nomenclature from NAFLD to MAFLD is more than a change in terminology
- Eileen Laurel Yoon, Dae Won Jun
- Received March 1, 2023 Accepted March 13, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0086 [Accepted]
-
View: 100 Download: 11
- Editorial: HCC surveillance in non-alcoholic fatty liver disease – who and how?
- Margaret LP Teng, Darren Jun Hao Tan, Cheng Han Ng, Daniel Q. Huang
- Received February 23, 2023 Accepted March 13, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0069 [Accepted]
-
View: 97 Download: 4
- Implications of comorbidities in nonalcoholic fatty liver disease
- Sherlot Juan Song, Vincent Wai-Sun Wong
- Received February 16, 2023 Accepted March 11, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0066 [Accepted]
-
View: 111 Download: 11
- Review
- Safety Considerations for Withdrawal of Nucleos(t)ide Analogues in Patients with Chronic Hepatitis B: First, Do No Harm
- Yao-Chun Hsu, Cheng-Hao Tseng, Jia-Horng Kao
- Received November 26, 2022 Accepted March 13, 2023
-
DOI: https://doi.org/10.3350/cmh.2022.0420 [Accepted]
-
View: 125 Download: 22
- Overview of Asian clinical practice guidelines for the management of hepatocellular carcinoma: Asian perspective comparison
- Yuri Cho, Bo Hyun Kim, Joong-Won Park
- Received March 9, 2023 Accepted March 9, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0099 [Accepted]
-
View: 187 Download: 29
- Editorial
- The prime time for management of hepatocellular carcinoma in Hong Kong
- Landon L. Chan, Stephen L. Chan
- Received March 7, 2023 Accepted March 8, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0094 [Accepted]
-
View: 109 Download: 5
- Non-obese or lean nonalcoholic fatty liver disease matters but is it preventable or inevitable in light of its risk factors?
- Heejoon Jang, Won Kim
- Received March 2, 2023 Accepted March 4, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0088 [Accepted]
-
View: 140 Download: 12
- The Imitator of Immune-Tolerant Phase in Chronic Hepatitis B: A Killer in Disguise
- Moon Haeng Hur, Jeong-Hoon Lee
- Received February 28, 2023 Accepted March 7, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0079 [Accepted]
-
View: 73 Download: 8
- The latest global burden of liver cancer: A past and present threat
- Joo Hyun Oh, Dae Won Jun
- Received February 23, 2023 Accepted March 4, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0070 [Accepted]
-
View: 95 Download: 11
- Lean vs. obese NAFLD, two phenotypes of NAFLD: look the same but different or vice versa?
- Ho Soo Chun, Minjong Lee
- Received February 15, 2023 Accepted March 6, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0061 [Accepted]
-
View: 85 Download: 12
- Review
- Hepatitis B core-related antigen: a novel and promising surrogate biomarker to guide anti-HBV therapy
- Takako Inoue, Takehisa Watanabe, Yasuhito Tanaka
- Received December 2, 2022 Accepted March 7, 2023
-
DOI: https://doi.org/10.3350/cmh.2022.0434 [Accepted]
-
View: 222 Download: 39
- Original Article
- Comparison of glucagon-like peptide-1 receptor agonists and thiazolidinediones on treating nonalcoholic fatty liver disease: A network meta-analysis
- Min Jeong Park, Hayeon Kim, Myeong Gyu Kim, Kyungim Kim
- Received October 22, 2022 Accepted March 6, 2023
-
DOI: https://doi.org/10.3350/cmh.2022.0330 [Accepted]
-
View: 174 Download: 18
- Editorial
- The growing burden of non-alcoholic fatty liver disease on mortality
- Ju-Yeon Cho, Won Sohn
- Received February 28, 2023 Accepted March 2, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0084 [Accepted]
-
View: 125 Download: 10
- How to optimize the outcome of liver transplantation for non-alcoholic fatty liver disease
- Byeong Geun Song, Dong Hyun Sinn
- Received January 5, 2023 Accepted February 27, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0058 [Accepted]
-
View: 130 Download: 7
- Review
- A decade of liver organoids: Advancements in disease modeling
- Yue Liu, Jian-Ying Sheng, Junjun Ding, Yun-Shen Chan
- Received November 29, 2022 Accepted February 28, 2023
-
DOI: https://doi.org/10.3350/cmh.2022.0428 [Accepted]
-
View: 245 Download: 52
- Original Article
- Analysis of Hepatitis C Virus Resistance-Associated Substitutions in Direct-Acting Antiviral Failure in South Korea Using Next-Generation Sequencing
- Kyung-Ah Kim, Sejoon Lee, Hye Jung Park, Eun Sun Jang, Youn Jae Lee, Sung Bum Cho, Young Suk Kim, In Hee Kim, Byung Seok Lee, Woo Jin Chung, Sang Hoon Ahn, Seungtaek Kim, Sook Hyang Jeong
- Received October 28, 2022 Accepted March 1, 2023
-
DOI: https://doi.org/10.3350/cmh.2022.0345 [Accepted]
-
View: 154 Download: 26
- Editorial
- Editorial: Noninvasive biomarkers for liver inflammation in NAFLD: current and future
- Kee-Huat Chuah, Wah-Kheong Chan
- Received February 15, 2023 Accepted February 23, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0062 [Accepted]
-
View: 120 Download: 10
- The Independent Effect of Exercise on Biopsy-Proven Non-Alcoholic Fatty Liver Disease: A Systematic Review
- Young-Joo Jin
- Received February 10, 2023 Accepted February 22, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0055 [Accepted]
-
View: 1440 Download: 33
- Snapshot
- Systemic therapy in advanced hepatocellular carcinoma
- Joseph C. Ahn, Nguyen H. Tran, Ju Dong Yang
- Received February 10, 2023 Accepted February 16, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0051 [Accepted]
-
View: 191 Download: 44
- Review
- Acute hepatitis C virus infection: clinical update and remaining challenges
- Chen-Hua Liu, Jia-Horng Kao
- Received October 30, 2022 Accepted February 16, 2023
-
DOI: https://doi.org/10.3350/cmh.2022.0349 [Accepted]
-
View: 369 Download: 89
- Original Article
- Taurocholic Acid Promotes Hepatic Stellate Cell Activation via S1PR2/p38 MAPK/YAP Signaling under Cholestatic Conditions
- Jing Yang, Xujiao Tang, Zhu Liang, Mingzhu Chen, Lixin Sun
- Received October 21, 2022 Accepted February 16, 2023
-
DOI: https://doi.org/10.3350/cmh.2022.0327 [Accepted]
-
View: 360 Download: 48
- Correspondance
- Correspondence on Letter regarding "The long-term prognosis and the need for histologic assessment in chronic hepatitis B in serological immune-tolerant phase"
- Jeong-Ju Yoo, Sang Gyune Kim
- Received February 6, 2023 Accepted February 9, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0044 [Accepted]
-
View: 108 Download: 6
- Review
- Development of hepatocellular carcinoma in untreated and treated patients with chronic hepatitis B virus infection
- Chih-Lin Lin, Jia-Horng Kao
- Received October 31, 2022 Accepted February 12, 2023
-
DOI: https://doi.org/10.3350/cmh.2022.0342 [Accepted]
-
View: 378 Download: 73
- Editorial
- Non-invasive biomarkers of liver fibrosis in NAFLD
- Basheer M, Naffaa ME, Assy N
- Received February 6, 2023 Accepted February 8, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0045 [Accepted]
-
View: 194 Download: 39
- Review
- Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in the era of chemo-diversity
- Hideki Iwamoto, Shigeo Shimose, Tomotake Shirono, Takashi Niizeki, Takumi Kawaguchi
- Received November 9, 2022 Accepted February 9, 2023
-
DOI: https://doi.org/10.3350/cmh.2022.0391 [Accepted]
-
View: 341 Download: 81
- Original Article
- Factors Associated with Unrecognized Cirrhosis in Patients with Hepatocellular Carcinoma
- Yi-Te Lee, Mohammad Karim, Hye Chung Kum, Sulki Park, Nicole E. Rich, Mazen Noureddin, Amit G. Singal, Ju Dong Yang
- Received December 15, 2022 Accepted January 29, 2023
-
DOI: https://doi.org/10.3350/cmh.2022.0450 [Accepted]
-
View: 393 Download: 35
- Review
- Neuropilins as potential biomarkers in hepatocellular carcinoma: a systematic review of basic and clinical implications
- Paula Fernández-Palanca, Tania Payo-Serafín, Carolina Méndez-Blanco, Beatriz San-Miguel, María J. Tuñón, Javier González-Gallego, José L. Mauriz
- Received November 28, 2022 Accepted January 31, 2023
-
DOI: https://doi.org/10.3350/cmh.2022.0425 [Accepted]
-
View: 335 Download: 39
- Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: Challenges and perspectives
- Shang-Chin Huang, Chun-Jen Liu
- Received November 27, 2022 Accepted January 5, 2023
-
DOI: https://doi.org/10.3350/cmh.2022.0422 [Epub ahead of print]
-
View: 522 Download: 120
- Letter to the Editor
- Letter to the Editor: Letter regarding "The long-term prognosis and the need for histologic assessment in chronic hepatitis B in serological immune-tolerant phase"
- Chia-Ming Chu, Yun-Fan Liaw.
- Received January 19, 2023 Accepted January 20, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0018 [Accepted]
-
View: 212 Download: 22
- Review
- Clinical practice guidelines and real-life practice for hepatocellular carcinoma in Taiwan
- Tung-Hung Su, Chih-Horng Wu, Tsung-Hao Liu, Cheng-Maw Ho, Chun-Jen Liu
- Received November 26, 2023 Accepted January 24, 2023
-
DOI: https://doi.org/10.3350/cmh.2022.0421 [Accepted]
-
View: 639 Download: 121
- Utility of Combining PIVKA-II and AFP in the Surveillance and Monitoring of Hepatocellular Carcinoma in the Asia-Pacific Region
- Do-Young KIM, Bao Nguyen TOAN, Chee-Kiat TAN, Irsan HASAN, Lyana SETIAWAN, Ming-Lung YU, Namiki IZUMI, Nguyen Nguyen HUYEN, Pierce Kah-Hoe CHOW, Rosmawati MOHAMED, Stephen Lam CHAN, Tawesak TANWANDEE, Teng-Yu LEE, Thi Thanh Nguyen HAI, Tian YANG, Woo-Chang LEE, Henry Lik Yuen CHAN
- Received July 19, 2022 Accepted January 25, 2023
-
DOI: https://doi.org/10.3350/cmh.2022.0212 [Accepted]
-
View: 729 Download: 170
- The role of different viral biomarkers on the management of chronic hepatitis B For special issue ‘Challenging issues in the treatment of viral hepatitis’
- Lung-Yi Mak, Rex Wan-Hin Hui, James Fung, Wai Kay Seto, Man-Fung Yuen
- Received December 14, 2022 Accepted January 15, 2023
-
DOI: https://doi.org/10.3350/cmh.2022.0448 [Accepted]
-
View: 432 Download: 75
- Clinical practice guideline and real-life practice in hepatocellular carcinoma: A Korean perspective
- Myung Ji Goh, Dong Hyun Sinn, Jong Man Kim, Min Woo Lee, Dong Ho Hyun, Jeong Il Yu, Jung Yong Hong, Moon Seok Choi
- Received November 16, 2022 Accepted January 1, 2023
-
DOI: https://doi.org/10.3350/cmh.2022.0404 [Epub ahead of print]
-
View: 467 Download: 51
- Original Article
- The long-term prognosis and the need for histologic assessment in chronic hepatitis B in serological immune-tolerant phase
- Jeong-Ju Yoo, Soo Young Park, Ji Eun Moon, Yu Rim Lee, Han Ah Lee, Jieun Lee, Young Seok Kim, Yeon Seok Seo, Sang Gyune Kim
- Received October 19, 2022 Accepted January 3, 2023
-
DOI: https://doi.org/10.3350/cmh.2022.0322 [Accepted]
-
View: 441 Download: 51
- Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences, 1990-2019: a DALYs-based analysis of the Global Burden of Disease 2019 study
- Sungchul Choi, Beom Kyung Kim, Dong Keon Yon, Seung Won Lee, Han Gyeol Lee, Ho Hyeok Chang, Seoyeon Park, Ai Koyanagi, Louis Jacob, Elena Dragioti, Joaquim Radua, Jae Il Shin, Seung Up Kim, Lee Smith
- Received October 17, 2022 Accepted December 27, 2022
-
DOI: https://doi.org/10.3350/cmh.2022.0316 [Accepted]
-
View: 721 Download: 92 Citation: 1
- Review
- Clinical practice guidelines and real-life practice on hepatocellular carcinoma: the Hong Kong perspective
- Rex Wan-Hin Hui, Lung-Yi Mak, Tan-To Cheung, Victor Ho-Fun Lee, Wai-Kay Seto, Man-Fung Yuen
- Received November 14, 2022 Accepted December 23, 2022
-
DOI: https://doi.org/10.3350/cmh.2022.0399 [Epub ahead of print]
-
View: 664 Download: 108
- Clinical practice guideline and real-life practice in hepatocellular carcinoma: Chinese perspective
- Diyang Xie, Jieyi Shi, Jian Zhou, Jia Fan, Qiang Gao
- Received November 15, 2022 Accepted December 20, 2022
-
DOI: https://doi.org/10.3350/cmh.2022.0402 [Accepted]
-
View: 801 Download: 174
- Original Article
- Single-cell phenotypes of peripheral blood immune cells in early and late stages of non-alcoholic fatty liver disease
- Kathryn Jane Waller, Hajar Saihi, Wenhao Li, James Hallimond Brindley, Anja De Jong, Wing-kin Syn, Conrad Bessant, William Alazawi
- Received July 14, 2022 Accepted November 16, 2022
-
DOI: https://doi.org/10.3350/cmh.2022.0205 [Epub ahead of print]
-
View: 793 Download: 56
